Um Endostim

Über das Unternehmen

EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders. It is performing clinical trials to pursue FDA approval for a new treatment for sphincter-related disorders such as gastroesophageal reflux disease (GERD) and urinary urge incontinence. Its microstimulator technology provides long-term reflux control by restoring normal esophageal function that directly targets the patient's weak or dysfunctional lower esophageal sphincter (LES) muscle between the stomach and the esophagus and enable patients to reduce or avoid typical gastrointestinal side effects of traditional anti-reflux surgery.